Latest market price
127.51
+0.88+0.69%
OverviewShort InterestFilings
KYMRQT60Kymera Therapeutics, Inc.·NASDAQ
127.51+0.69%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 29, 20268-KCurrent report
Oct 29, 202610-QQuarterly report
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 01, 20264Statement of changes in beneficial ownership
Sep 08, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Sep 04, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 05, 20268-KCurrent report
Aug 05, 202610-QQuarterly report
Jul 27, 20268-KCurrent report
Jul 27, 20264Statement of changes in beneficial ownership
Jul 27, 20263Initial statement of beneficial ownership
Jul 07, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264/AStatement of changes in beneficial ownership (amended)
Jun 30, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 26, 2026SC 13D/ABeneficial ownership statement (active, amended)
Jun 26, 20264Statement of changes in beneficial ownership
Jun 25, 20264Statement of changes in beneficial ownership
Jun 25, 20268-KCurrent report
Jun 25, 20264Statement of changes in beneficial ownership
#1 / 25 of 409
Page
▼
/ 17